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summary
Vitamin D deficiency is very common in patients with rheumatoid arthritis (RA). Aim of this study was to 
evaluate the prevalence of vitamin D deficiency among the different Italian regions and whether these variations 
are associated with different severity of the disease.
The study includes 581 consecutive RA patients (464 women), not taking vitamin D supplements, from 22 
Italian rheumatology centres uniformly distributed across Italy. Together with parameters of disease activity 
(disease activity score 28), functional impairment (activities of daily living and health assessment questionnaire 
disability index) and mean sun exposure time, all patients had serum 25-hydroxyvitamin D (25OHD) measured 
in a centralized laboratory.
Vitamin D deficiency (25OHD level <20 ng/mL) was very frequent among RA patients; its prevalence was 
60%, 52% and 38% in southern, central and northern Italy, respectively. Mean disease activity and disability 
scores were worse in southern regions of Italy. These scores were inversely related to 25OHD levels and this 
correlation remained statistically significant after adjusting for both body mass index (BMI) and sun exposure 
time. However, disease severity remained significantly higher in southern regions versus central-northern Italy 
after adjustment also for serum 25OHD levels, age and BMI.
In RA Italian patients there are significant regional differences in the prevalence of vitamin D deficiency ex-
plained by different BMI, and sun exposure time, and inversely associated with disease activity and disability 
scores. 
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n	 INTRODUCTION 
Vitamin D deficiency is extremely common in Europe and particularly 
in Southern countries (1, 2), not only in 
elder people but also among young sub-
jects (3). Recently in an Italian multicen-
tric study (4), involving more than one 
thousand patients affected by rheumatoid 
arthritis (RA), we showed that more than 
half of the patients was vitamin D defi-
cient, defined as serum 25-hydroxyvitamin 
D (25OHD) concentration <20 ng/mL (5, 
6). In the same study (4) we confirmed 
that the main determinants of serum vita-
min D level are also in RA patients body 
mass index (BMI) and sun exposure time. 
A significant inverse correlation was found 
between 25OHD serum level and disease 
activity or disability scores (4), while bone 
erosions were associated with higher para-
thyroid hormone levels (7). Similar find-
ings in smaller cohort of patients were re-
ported by other authors (8-10), but not all 
(11-13). The causal link between vitamin 
D deficiency and disease severity could not 
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be ascertained since sun exposure time was 
also lower in these patients and sun expo-
sure may be dependent on disease severity 
and then the propensity to stay outside.
The aim of this sub-analysis of the Italian 
multicentric study (4) is to evaluate the re-
gional differences in the prevalence of vi-
tamin D deficiency, and whether these are 
associated with differences in the activity 
of the disease. 
n	 MATERIALS AND METHODS
Patients
This is a subgroup analysis of the patients 
not taking vitamin D supplements and par-
ticipating in the Italian multicentre study 
on vitamin D status in RA patients, spon-
sored by the Italian Rheumatology Society 
(4). The study population includes 581 
consecutives patients (464 females, 117 
males) aged between 30 and 75 years affer-
ent to 22 rheumatologic clinics equally dis-
tributed over Italy (6 in the North, 8 in the 
Center and 8 in the South; Figure 1). The 
diagnosis of RA was made according to the 
American College of Rheumatology 1987 
criteria (14). Subjects with comorbilities 
such as insulin-dependent diabetes or se-
vere renal or hepatic failure were excluded.
The study was in compliance with the 
Helsinki Declaration and was approved by 
the local Ethical Committees. An informed 
written consent was obtained from all par-
ticipants.
Clinical evaluation
All patients were interviewed and exam-
ined at each clinical center for the gather-
ing of information on disease and treatment 
history. Disease-related variables included 
disease onset and duration, presence of ex-
tra-articular manifestations, 28 tender joint 
count (TJC28) and 28 swollen joint count 
(SJC28). The three-variable disease activ-
ity score (DAS 28) was calculated using 
C-reactive protein (CRP) and the Nijmegen 
formula (15): DAS28=(0.56*sqrt(TJC28) 
+ 0.28*sqrt (SJC28) + 0.36*ln(CRP+1)) 
*1.10 + 1.15. Clinical measures of disease 
related functional impairment included 
health assessment questionnaire disability 
index (HAQ), and the mobility activities of 
daily living (ADL). RA specific treatment 
details were collected for glucocorticoids, 
disease modifying anti-rheumatic drugs: 
methotrexate, cyclosporine, gold salts, sul-
fasalazine, antimalarials, and azathioprine, 
and the tumor necrosis factor-α blockers 
(anti-TNF). Patients were interviewed re-
garding current use of drugs affecting bone 
metabolism including bisphosphonates, 
calcium and vitamin D supplements.
Exposure to sunlight from March to 
September (sun exposure time) was quan-
tified with a semiquantitative scale from 0 
to 3 as follow: <10, 10 to 20, 20 to 30 or 
>30 min daily (4). Body weight and height 
(Harpender stadiometer) were assessed and 
the BMI (kg/m²) was calculated in all sub-
jects.
Laboratory assessment
Rheumatoid factor, anti-cyclic citrullinat-
ed peptide and routine biochemistry were 
Figure 1 - Geographic distribution of the centres participating in the 
study.
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Figure 2 - Prevalence of hypo-vitaminosis D in the north, center and south of Italy. 25OHD, 
25-hydroxyvitamin D.
Figure 3 - Seasonal variations of 25-hydroxyvitamin D (25OHD) serum level (box-plots) in the 
north, center and south of Italy.
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measured locally. Serum samples were col-
lected from June 2007 to May 2008 from 
each patient and 4 aliquots were sent on 
dry ice by courier to the laboratory of the 
University of Verona, and kept at -70°C 
until the measurement of serum 25OHD 
using commercial ELISA kits (IDS Co., 
Bolden, UK) with inter-assay coefficient of 
variations ranging from 5 to 15%.
Statistical analysis
All data management and analysis were 
centralized and conducted by one of the 
centres. The differences between sub-
groups were assessed by t-test or analysis 
of variance (ANOVA); analysis of covari-
ance (ANCOVA) was used to adjust values 
for confounding factor. Chi-square tests 
were used for categorical data. 
Associations between continuous variables 
were examined using Pearson correlation 
coefficients (r) and multivariate linear re-
gression. Differences were considered sig-
nificant at P<0.05. 
All statistical procedures were carried out 
using a medical statistics computer pro-
gram (SPSS version 13.0, Inc., Chicago, 
IL, USA).
n	 RESULTS
The study patients were divided in three 
subgroups by regions of residence in the 
north, the center or the south of Italy. The 
mean age (56±11 years) and disease dura-
tion (132±105 months) were not significant 
different in the 3 subgroups of patients. 
Similar were also the seasonal distribu-
tion of serum sampling and the RA specific 
treatment. 
Significant differences between north-cen-
ter and south were observed in BMI (25.0 
vs 25.8, respectively, P=0.033) and in de-
gree of sun exposure time score (1.8 vs 1.6, 
respectively, P=0.02).
The prevalence of vitamin D deficiency 
(25OHD<20 ng/mL) was more common 
Figure 4 - Disease activity score 28 (DAS28), activities of daily living (ADL) and health assess-
ment questionnaire disability index (HAQ) (mean±SE) in the north-center and south of Italy.
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(P<0.01) in the south and centre than in the 
north (60.1%, 51.8%, and 37.5%, respec-
tively) (Fig. 2).
The mean 25OHD levels in each macro-
region are shown in Figure 3, accord-
ing with the season of blood collection: a 
seasonal trend was apparent but the lower 
mean 25OHD serum levels in the south 
were confirmed (P<0.05) also for values 
adjusted for the month of blood collection. 
The mean DAS 28, HAQ and ADL scores 
were higher in the south as compared to 
center-north regions (4.1 vs 3.7; 1.28 vs 
0.91; 8.74 vs 7.36, respectively; P<0.001) 
(Fig. 4). 
25OHD serum level correlates negatively 
with age (P<0.05) and BMI (P<0.001), 
and positively with sun exposure time 
(P<0.001). 
Negative significant correlations were 
found between 25OHD levels and HAQ 
(r=-0.20; P<0.001) or DAS28 (r=-0.17, 
P<0.001) (Fig. 5). These correlations re-
mained significant after correction for the 
determinants of vitamin D status, such as 
BMI and sun exposure time. 
The mean DAS 28, HAQ and ADL scores 
remained significantly higher in the south 
as compared to northern and central re-
gions (P<0.001) also after adjustment for 
25OHD serum levels, age and BMI. 
n	 DISCUSSION
It was reported that the risk of vitamin D 
deficiency rises with the latitude possibly 
as a consequence of lower number of hours 
of efficient sunlight (16). In this study we 
observed that RA patients living in south-
ern Italy are at higher risk of hypo-vitamin-
osis D than patients living in central-north-
ern Italy, despite the average latitude was 
38 and 45 for the rheumathology centres 
of southern and northern regions, respec-
tively. Seasonal variation of 25OHD serum 
level was somewhat more visible in the 
south than in the north, with the expected 
nadir values at the end of winter and at the 
beginning of spring.
Interestingly, similar observations were re-
ported in 4 surveys on elderly populations 
of Europe, with the prevalence of vitamin 
D insufficiency being higher in southern 
Europe (1, 2, 17, 18).
Our findings may be explained at least in 
part by the significantly higher mean BMI 
values observed in patients from south Italy, 
since BMI is known to be inversely associ-
ated to serun levels of 25OHD (4). Another 
explanation is that more hours of sunlight 
do not mean necessarily longer sun expo-
sure! During summer but also spring, sun-
light is so burning that traditionally people 
Figure 5 - Correlations between 25-hydroxyvitamin D (25OHD) serum levels, health assess-
ment questionnaire disability index (HAQ) and disease activity score 28 (DAS28). 
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living in southern Mediterranean regions 
avoid sunlight exposure. Indeed, in our pa-
tients series sun exposure was significantly 
shorter in the south as compared to center-
north Italy.
In our study we observed that both disease 
activity and disability scores were worst in 
patients living in the southern regions. Of 
interest are the observed correlations be-
tween 25OHD serum levels and disease ac-
tivity (DAS28) and disability scores (HAQ 
and ADL) that remained significant after 
correction for BMI (data not shown). 
The explanation of this finding is not clear 
since we are not in the condition to control 
for a number of factors such as the selec-
tion of the patients included in the study 
and the average standard of care. However 
these correlations remained significant 
also by analyzing only southern patients. 
Twelve studies evaluated the association 
between 25OHD levels and RA (4, 8-13, 
19-23). 
Nine of these studies showed that 25OHD 
serum levels are inversely associated with 
RA activity, such as, DAS28. It is conceiv-
able that patients with more severe disease 
are also likely to spend less hours out-door, 
and that this may lead to lower 25OHD 
levels in not supplemented patients, but the 
25OHD difference between south and north 
Italy and the correlation between 25OHD 
levels and disease activity or functional im-
pairment, remained statistically significant 
also when the 25OHD levels were adjusted 
for sun exposure time. 
This latter observation might be explained 
by the recent report that 25OHD serum 
concentration decreases in inflammatory 
conditions (24) generating a vicious circle 
where inflammation is responsible of lower 
25OHD levels which, in turn, might lead 
to worsening of the disease as suggested 
by the multiple effects of vitamin D on im-
mune system (25) and muscle performance 
(26). 
Our findings are far from conclusive in 
establishing a causal relationship between 
low 25OHD levels and disease severity in 
RA patients. We have been unable to con-
trol the clinical data for the standard of care 
and we cannot exclude that patients seen 
in the secondary care centers of the south 
of Italy are more selected for their sever-
ity. The causality link between low 25OHD 
levels and disease severity can be deter-
mined only with longitudinal intervention 
studies.
Nevertheless the mean DAS 28, HAQ and 
ADL scores remained significantly higher 
in the south as compared to northern and 
central regions also after adjustment for 
25OHD serum levels. The poorer control 
of disease activity in southern Italy is like-
ly to be related to other factors. 
Recently, a deleterious effects of higher 
BMI on clinical control of RA (27) and 
on the response to treatment (28) was re-
ported and, indeed, in our study signifi-
cantly higher BMI values were observed 
in southern regions, but in a multivariate 
analysis the correlation of BMI with clini-
cal scores was not significant. 
In conclusion in RA Italian patients there 
are significant regional differences in the 
prevalence of vitamin D deficiency and 
these are associated with different disease 
activity and disability scores. 
Even though a causal link between vitamin 
D deficiency and RA severity remains to 
be established, our results indicate that vi-
tamin D supplementation must be recom-
mended to all patients even if only for the 
prevention of secondary osteoporosis (29).
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